Geode Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2M | Buy |
1,825,602
+153,012
| +9% | +$2.45M | ﹤0.01% | 1750 |
|
|
2025
Q1 | $28.6M | Buy |
1,672,590
+157,570
| +10% | +$2.69M | ﹤0.01% | 1698 |
|
|
2024
Q4 | $37.5M | Buy |
1,515,020
+4,094
| +0.3% | +$101K | ﹤0.01% | 1613 |
|
|
2024
Q3 | $43.1M | Buy |
1,510,926
+96,924
| +7% | +$2.76M | ﹤0.01% | 1510 |
|
|
2024
Q2 | $37.3M | Buy |
1,414,002
+97,175
| +7% | +$2.57M | ﹤0.01% | 1552 |
|
|
2024
Q1 | $42.6M | Buy |
1,316,827
+43,861
| +3% | +$1.42M | ﹤0.01% | 1462 |
|
|
2023
Q4 | $53.6M | Buy |
1,272,966
+128,632
| +11% | +$5.42M | 0.01% | 1303 |
|
|
2023
Q3 | $43.9M | Sell |
1,144,334
-26,189
| -2% | -$1.01M | 0.01% | 1314 |
|
|
2023
Q2 | $22.2M | Buy |
1,170,523
+121,805
| +12% | +$2.31M | ﹤0.01% | 1783 |
|
|
2023
Q1 | $16.3M | Buy |
1,048,718
+45,123
| +4% | +$700K | ﹤0.01% | 1935 |
|
|
2022
Q4 | $17.8M | Buy |
1,003,595
+189,926
| +23% | +$3.37M | ﹤0.01% | 1847 |
|
|
2022
Q3 | $4.54M | Buy |
813,669
+18,697
| +2% | +$104K | ﹤0.01% | 2731 |
|
|
2022
Q2 | $3.1M | Buy |
794,972
+6,134
| +0.8% | +$23.9K | ﹤0.01% | 2955 |
|
|
2022
Q1 | $4.35M | Sell |
788,838
-31,561
| -4% | -$174K | ﹤0.01% | 2876 |
|
|
2021
Q4 | $6.99M | Sell |
820,399
-35,509
| -4% | -$303K | ﹤0.01% | 2690 |
|
|
2021
Q3 | $7.44M | Buy |
855,908
+8,798
| +1% | +$76.4K | ﹤0.01% | 2681 |
|
|
2021
Q2 | $8.95M | Buy |
847,110
+51,790
| +7% | +$547K | ﹤0.01% | 2532 |
|
|
2021
Q1 | $12.8M | Buy |
795,320
+40,830
| +5% | +$655K | ﹤0.01% | 2191 |
|
|
2020
Q4 | $34.8M | Buy |
754,490
+196,009
| +35% | +$9.05M | 0.01% | 1366 |
|
|
2020
Q3 | $19.7M | Buy |
558,481
+196,912
| +54% | +$6.93M | ﹤0.01% | 1546 |
|
|
2020
Q2 | $8.8M | Buy |
361,569
+342,394
| +1,786% | +$8.34M | ﹤0.01% | 1998 |
|
|
2020
Q1 | $298K | Buy |
+19,175
| New | +$298K | ﹤0.01% | 3430 |
|